Ameriprise’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-11,020
| Closed | -$32K | – | 3762 |
|
2020
Q1 | $32K | Sell |
11,020
-255,817
| -96% | -$743K | ﹤0.01% | 3595 |
|
2019
Q4 | $1.01M | Sell |
266,837
-752,158
| -74% | -$2.85M | ﹤0.01% | 3047 |
|
2019
Q3 | $5.21M | Buy |
1,018,995
+244,700
| +32% | +$1.25M | ﹤0.01% | 2189 |
|
2019
Q2 | $4.8M | Buy |
774,295
+623,705
| +414% | +$3.87M | ﹤0.01% | 2278 |
|
2019
Q1 | $1.07M | Sell |
150,590
-253
| -0.2% | -$1.8K | ﹤0.01% | 3002 |
|
2018
Q4 | $1.29M | Buy |
+150,843
| New | +$1.29M | ﹤0.01% | 2835 |
|
2018
Q1 | – | Sell |
-54,295
| Closed | -$1.84M | – | 3714 |
|
2017
Q4 | $1.84M | Buy |
+54,295
| New | +$1.84M | ﹤0.01% | 2688 |
|
2016
Q1 | – | Sell |
-64,978
| Closed | -$1.84M | – | 3881 |
|
2015
Q4 | $1.84M | Buy |
+64,978
| New | +$1.84M | ﹤0.01% | 2646 |
|